Dailypharm Live Search Close

Reduction in the scope of platform regulation & re-examinati

By Lee, Jeong-Hwan | translator Kim, Jung-Ju

23.08.24 17:20:19

°¡³ª´Ù¶ó 0
Another number of non-face-to-face legislative issues

Criticism of some lawmakers, "Welfare Ministry, demanding only swift legislation without countermeasures for side effects"


Following the decision to postpone the non-face-to-face treatment institutionalization bill again by the National Assembly Health and Welfare Committee on the 24th, it is evaluated that the number of issues to be resolved for legislation has increased. At the same time, the need to reduce the scope of non-face-to-face treatment patients compared to the current pilot project was raised, and criticism followed that there was no mechanism to regulate illegal and expedient actions by mediation platform companies.

Furthermore, as a result of the pilot project that has been in effect since last June, it is still difficult to punish without distinguishing first-time and returning patients in non-face-to-face

Lee, Jeong-Hwan(junghwanss@dailypharm.com)
If you want to see the full article, please JOIN US (click)